Zeneca launches cancer diagnostic kit:
This article was originally published in Clinica
Uk-based Zeneca Diagnostics has launched its first cancer diagnostic kit, Elucigene K-RAS7, in Europe. The test detects the seven most common mutations in the K-ras proto-oncogene, found in the DNA of many types of cancer cells - including bowel, pancreatic and lung cancer. Zeneca claims the test is sufficiently sensitive to spot K-ras mutations even in samples containing predominantly normal tissue. It can thus give early warning of malignancy as well as typing and monitoring of known tumours. The kit is the fourth in the Elucigene series.